Publication

Targeting the DNA damage response in cervical cancer

Wieringa, H., 2017, [Groningen]: Rijksuniversiteit Groningen. 148 p.

Research output: ThesisThesis fully internal (DIV)

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 173 KB, PDF document

  • Chapter 1

    Final publisher's version, 931 KB, PDF document

  • Chapter 2

    Final publisher's version, 2.19 MB, PDF document

  • Chapter 3

    Final publisher's version, 5.38 MB, PDF document

  • Chapter 4

    Final publisher's version, 21.3 MB, PDF document

  • Chapter 5

    Final publisher's version, 6.25 MB, PDF document

  • Chapter 6

    Final publisher's version, 10.1 MB, PDF document

  • Chapter 7

    Final publisher's version, 972 KB, PDF document

  • Appendices

    Final publisher's version, 923 KB, PDF document

  • Complete thesis

    Final publisher's version, 42.1 MB, PDF document

  • Propositions

    Final publisher's version, 128 KB, PDF document

Therapy improvement of cervical cancer by inhibition of DNA repair in tumor cells Treatment of locally-advanced cervical cancer consists of combined radio- and chemotherapy. Five-year survival of these patients is 66%. To further improve overall survival in cervical cancer patients, it is necessary to develop novel treatment modalities. It is suggested that inhibition of the DNA repair of tumor cells could be a way to sensitize cervical cancer cells for radio- and chemotherapy.

Radio- and chemotherapy kill tumor cells (as well as normal cells) by induction of high amounts of DNA damage. This damage is not only repaired in normal cells, but also in tumor cells. Like in other cancer types, part of the signaling pathway involved in DNA repair in cervical cancer cells is defective. Consequently, cells increasingly depend on the remaining functional signaling pathways. The aim of this thesis was to investigate which of these remaining pathway components is the most promising candidate therapeutic target in cervical cancer cells to improve sensitization for radio- and chemotherapy.

In this thesis, we show that inhibition of the ATR-Chk1 signaling pathway is the most efficient way to increase the effects of radio- and chemotherapy in cervical cancer cells. The results of this thesis may contribute to further improve the survival of cervical cancer patients.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
Award date12-Apr-2017
Place of Publication[Groningen]
Publisher
Print ISBNs978-90367-9656-9
Electronic ISBNs978-90367-9657-6
Publication statusPublished - 2017

Download statistics

No data available

ID: 41032280